FendX's Nanotechnology to Be Presented at the Canadian Chemistry Conference and Exhibition, CSC 2024
FendX Technologies will present its nanotechnology advancements at the 107th Canadian Chemistry Conference and Exhibition (CSC 2024) in Winnipeg, Manitoba, on June 6, 2024. Professor Tohid Didar from McMaster University will discuss FendX's REPELWRAP™ film and spray nanotechnology in a talk titled 'Nano-engineered interfaces for diagnostics, therapeutics, and infection control.' This event showcases Canadian chemistry research and innovation, providing a platform for FendX to highlight its progress in developing surface protection coatings for high-touch areas prone to contamination.
- FendX Technologies will present at CSC 2024, a prominent Canadian chemistry event, enhancing its visibility.
- Presentation by Professor Tohid Didar from McMaster University, a reputable institution, underscores the credibility of the research.
- Showcasing REPELWRAP™ film and spray nanotechnology, highlighting innovation in surface protection coatings.
- Potential for increased investor interest due to the high-profile nature of the event and the innovative focus of the presentation.
- The announcement lacks specific financial data or clear metrics indicating the current market performance or revenue impact.
- No information on commercialization timelines or market readiness for REPELWRAP™ technology is provided.
Oakville, Ontario--(Newsfile Corp. - May 30, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings, is pleased to announce that development advances associated with its nanotechnology will be presented at the 107th Canadian Chemistry Conference and Exhibition, CSC 2024, being held in Winnipeg, Manitoba.
On June 6, 2024, Professor Tohid Didar, one of the lead researchers of FendX's nanotechnology development projects at McMaster University, will give an invited talk entitled "Nano-engineered interfaces for diagnostics, therapeutics and infection control" where FendX's REPELWRAP™ film and spray nanotechnology will be presented. CSC 2024 provides a forum for learning, knowledge exchange, innovation and highlights advances of Canadian chemistry research.
"These types of events are always a great venue to showcase our nanotechnology and highlight advances we are making to develop products to protect high touch surfaces prone to contamination, which is accomplished in collaboration with our esteemed colleagues at McMaster University," said Dr. Carolyn Myers, President and CEO of FendX.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has exclusive worldwide licenses to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
Alyssa Barry, Investor Relations
1-833-947-5227
investor@fendxtech.com
For more information, please visit https://fendxtech.com/ and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; products under development; and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. The reader is urged to refer to such public filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211053
FAQ
What will FendX Technologies present at CSC 2024?
When is the FendX Technologies presentation at CSC 2024?
Who will present FendX Technologies' nanotechnology at CSC 2024?
What is the focus of Professor Tohid Didar's talk at CSC 2024?
What is the significance of FendX Technologies presenting at CSC 2024?
